Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q3 2023 Earnings Call Transcript

Page 6 of 6

Jason Mccarthy: Great. Looking forward to the data in January.

James Caruso: Yes. Thanks so much, Jason. I appreciate it.

Operator: And there are no further questions at this time. So I will hand back to management. Please proceed.

James Caruso: Okay. Thank you, operator. And certainly, thank you to all of our participants today. I thought we had a lot of great questions. Since there are no more questions, we’ll now close our discussion. Very appreciative of all of you joining us today, as I cited earlier, and we certainly look forward to updating you on our next call and obviously, sharing with you our top line data from our WN pivotal trial, which we believe will be transformational for the future of our company. We thank you.

Operator: Ladies and gentlemen, this concludes your conference call for today. We thank you for participating. May I ask that you please disconnect your lines.

Follow Cellectar Biosciences Inc. (NASDAQ:CLRB)

Page 6 of 6